Description
The Atrial Fibrillation Genetics Consortium (AFGen) was organized to identify common and rare genetic variation associated with atrial fibrillation risk. In the current study, we have performed whole genome sequencing in cases with early-onset atrial fibrillation. Samples in this study were enrolled as a part of the Partners HealthCare Biobank. Cases with early-onset atrial fibrillation were identified from the Biobank (defined as atrial fibrillation onset prior to 61 years and in the absence of structural heart disease).
Summary
PlatformsBDC
Consent CodesHMB
Focus / DiseasesAtrial Fibrillation
Study DesignCase Set
Data TypesSNP/CNV Genotypes (NGS), WGS
Subjects128